Stocks
P&G Health Sees 30% PAT Rise in FY26
Procter & Gamble Health Limited reported a significant increase in Profit After Tax (PAT) for the fiscal year ended March 31, 2026. The company's PAT rose by 30% to ₹327 crore, compared to the same period last year. Revenue from operations stood at ₹1,385 crore, an improvement of 16% over the indexed period.
The company attributed the growth to its focus on superior innovations backed by science, strengthened go-to-market capabilities, and productivity initiatives. In the fourth quarter, sales rose 20% to ₹365 crore, while PAT increased by 55% to ₹95 crore.
The Board has recommended a final dividend of ₹45 per share for the financial year ended March 31, 2026. This brings the total dividend payout for the fiscal to ₹205 per share.